U.S. market Closed. Opens in 2 days 6 hours 28 minutes

MIST | Milestone Pharmaceuticals Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
Revenue1.00M5.00M15.00MN/AN/AN/AN/A
Cost of Revenue598.00K480.00KN/A376.00K236.00KN/AN/A
Gross Profit402.00K4.52M15.00M-376.00K-236.00KN/AN/A
Operating Expenses61.81M64.64M58.07M50.71M57.88M23.82M8.27M
Selling, General & Admin30.54M24.81M19.40M16.22M15.90M6.97M2.63M
Research & Development31.27M39.83M38.67M34.49M41.98M16.85M5.64M
Other Operating Expenses-312.00KN/A7.00MN/AN/AN/AN/A
Operating Income-61.41M-59.64M-43.07M-50.71M-57.88M-23.82M-8.27M
Other Expenses / Income1.41M1.25M220.00K726.00K2.60M711.00K186.00K
Before Tax Income-60.00M-58.39M-42.85M-49.98M-55.28M-23.11M-8.08M
Income Tax Expenses-312.00K-1.25M-220.00K-17.00K-56.00K74.00K4.00K
Net Income-59.69M-57.13M-42.63M-49.97M-55.23M-23.18M-8.09M
Interest Expenses2.55M-1.25MN/A726.00K2.60MN/AN/A
Basic Shares Outstanding42.96M42.45M41.83M29.34M15.78M23.65M23.65M
Diluted Shares Outstanding42.96M42.45M41.83M29.34M15.78M23.65M23.65M
EBITDA-60.81M-59.64M-42.98M-50.61M-57.84M-23.81M-8.07M
EBITDA Margin-6,081.20%-1,192.84%-286.53%0.00%0.00%0.00%0.00%
EBIT-57.44M-59.64M-42.85M-49.26M-52.69M-23.11M-8.08M
EBIT Margin-5,744.30%-1,192.84%-285.69%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙